According to I-Mab Biopharma's latest financial reports the company's current earnings (TTM) are -A$15.42 M. In 2022 the company made an earning of -A$0.54 B an increase over its 2021 earnings that were of -A$0.55 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.